FFCP PHASE1:Hg19::chr16:29656517..29656522,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(One intermediate revision by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr16:29656517..29656522,- | |||
|coexpression_cluster_id=C1218 | |||
|description=CAGE_peak_at_chr16:29656517..29656522,- | |||
|id=chr16:29656517..29656522,- | |||
|ontology_enrichment_celltype=CL:0000988!7.12e-15!182;CL:0000037!3.86e-14!172;CL:0000566!3.86e-14!172;CL:0002032!7.12e-13!165;CL:0000837!7.12e-13!165;CL:0000945!7.37e-12!24;CL:0000826!7.37e-12!24;CL:0000817!4.02e-11!3;CL:0000785!6.44e-08!2;CL:0000955!6.44e-08!2;CL:0000818!6.44e-08!2;CL:0000954!6.44e-08!2;CL:0000816!6.44e-08!2;CL:0000763!2.62e-07!112;CL:0000049!2.62e-07!112 | |||
|ontology_enrichment_celltype_v019=CL:0000946;9.99e-30;1!CL:0000786;9.99e-30;1!CL:0000817;2.73e-29;1!CL:0000945;2.31e-11;24 | |||
|ontology_enrichment_celltype_v019_2=CL:0000817,2.18e-38,3;CL:0000946,9.99e-30,1;CL:0000786,9.99e-30,1;CL:0000980,9.99e-30,1;CL:0000785,1.33e-15,2;CL:0000955,1.33e-15,2;CL:0000818,1.33e-15,2;CL:0000954,1.33e-15,2;CL:0000816,1.33e-15,2;CL:0000945,2.43e-11,24;CL:0000826,2.43e-11,24;CL:0000838,3.09e-09,52;CL:0000542,4.53e-09,53;CL:0000051,4.53e-09,53;CL:0000236,4.56e-09,14;CL:0002032,9.40e-09,161;CL:0000837,9.40e-09,161;CL:0000037,2.15e-08,168;CL:0000988,5.65e-08,177 | |||
|ontology_enrichment_development_v019=CL:0000954;1.33e-15;2 | |||
|ontology_enrichment_disease=DOID:2531!8.23e-34!51;DOID:0060083!8.23e-34!51;DOID:8692!3.54e-23!31;DOID:1240!6.15e-23!39;DOID:0050686!1.27e-19!137;DOID:0060058!4.14e-15!10;DOID:162!2.33e-14!235;DOID:14566!7.59e-14!239;DOID:74!2.23e-07!2 | |||
|ontology_enrichment_disease_v019=DOID:2355;1.33e-29;1!DOID:74;1.54e-15;2!DOID:1240;7.60e-15;39!DOID:2531;7.47e-12;51!DOID:0060083;7.47e-12;51!DOID:8692;1.04e-08;31!DOID:1287;1.96e-08;4 | |||
|ontology_enrichment_disease_v019_2=DOID:2355,1.33e-29,1;DOID:2531,3.72e-20,51;DOID:0060083,3.72e-20,51;DOID:1240,2.06e-18,39;DOID:74,1.54e-15,2;DOID:8692,6.70e-09,31;DOID:1287,1.96e-08,4;DOID:0050686,1.38e-07,137 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.916960868975415,0.656804715599566,0.472264687882075,0,0.383829398097213,0,0,0,0,0.154934401160603,0.284338464974843,0.880801318004542,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.560508562981536,0.263384084775077,0,0,0,0,0,0,0,0.111410456885174,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.087834785693126,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.441463099414651,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.215915916102139,0,0,0,0,0,0,0,0.261435451024901,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.106824071127473,0,0,0,1.00988449083511,0,0,0.199579371432817,0.383010740264733,0.423347165447766,0,0,0.228234679033192,0.626719583092093,0,0,0.321176150207399,0.201799707191048,1.27753871307098,1.03051603426729,0,0,0,0,0,1.23087398947712,0.270455678475983,0.99921590399346,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.369254416383208,0,0,0,0,0,0,0,0,0,0,0,0,0,0.1137934482855,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.498635045700469,0,0,0,0.75901493089674,0.794682894901893,0.421996129056054,0,0,0,0,0,0,0,0.247127877893006,0.104421949505455,0,0,0,0.547364367646998,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.174118413160805,0,0,0,0,0,0,0,0,0.137041924646751,0,0,0,0,0,0,0,0,0,0,0,0,0,0.104602846312333,0.101998217636322,0,0,0,0,0.429765441419957,5.25774708558629,0,0,0,0,0,0,0,0,0,0,0,0,0,2.28617996577618,0,0,0,0,0,0,0.77380195455795,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.82092520749339,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.124980407962107,0.303298235083296,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.400027764663154,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.194860308839388,0,0.163565394255844,0,0,0,0.39997479170986,0.106691729694141,0,0.567515953566836,0,0,0,0,0,0,0,0,0,0.247871528518004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.11796972334774,0,0,0,0.690359926060101,0,0,0,0,0,0.327543835020193,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.22655165156182,0,0,0,0,0,0,0,0,0.913158720509496,0,0,0,0,0.116241425368125,0,0,0,0,0,0,0,0,0,0,0,0.955538938977433,0,0.098150233615243,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.799529247399431,0,0.352894871715692,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr16:29656517..29656522,- | |||
}} |
Latest revision as of 07:51, 25 July 2015
Short description: | p@chr16:29656517..29656522, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr16:29656517..29656522, - |
Coexpression cluster: | C1218_hairy_plasma_lymphoma_xeroderma_hereditary_mycosis_splenic |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
precursor B cell | 2.18e-38 | 3 |
antibody secreting cell | 9.99e-30 | 1 |
plasma cell | 9.99e-30 | 1 |
plasmablast | 9.99e-30 | 1 |
mature B cell | 1.33e-15 | 2 |
pre-B-II cell | 1.33e-15 | 2 |
transitional stage B cell | 1.33e-15 | 2 |
small pre-B-II cell | 1.33e-15 | 2 |
immature B cell | 1.33e-15 | 2 |
lymphocyte of B lineage | 2.43e-11 | 24 |
pro-B cell | 2.43e-11 | 24 |
lymphoid lineage restricted progenitor cell | 3.09e-09 | 52 |
lymphocyte | 4.53e-09 | 53 |
common lymphoid progenitor | 4.53e-09 | 53 |
B cell | 4.56e-09 | 14 |
hematopoietic oligopotent progenitor cell | 9.40e-09 | 161 |
hematopoietic multipotent progenitor cell | 9.40e-09 | 161 |
hematopoietic stem cell | 2.15e-08 | 168 |
hematopoietic cell | 5.65e-08 | 177 |
Ontology term | p-value | n |
---|---|---|
anemia | 1.33e-29 | 1 |
hematologic cancer | 3.72e-20 | 51 |
immune system cancer | 3.72e-20 | 51 |
leukemia | 2.06e-18 | 39 |
hematopoietic system disease | 1.54e-15 | 2 |
myeloid leukemia | 6.70e-09 | 31 |
cardiovascular system disease | 1.96e-08 | 4 |
organ system cancer | 1.38e-07 | 137 |